Clik here to view.
Second Sight’s Argus II Retinal Prosthesis Implanted in First Patient in Asia
SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to...
View ArticleClik here to view.
Hallstar’s Breakthrough Anti-Aging Chemistry, Micah, Takes Silver at the...
CHICAGO Hallstar, a specialty chemical company based in Chicago, has been awarded the 2017 Global in-cosmetics® Innovation Silver Prize for its revolutionary new anti-aging ingredient, Micah....
View ArticleClik here to view.
Zoetis to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody...
PARSIPPANY, N.J. & TULLAMORE, Ireland Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced an agreement in which Zoetis, through a wholly owned subsidiary (“Zoetis...
View ArticleClik here to view.
武田与NuBiyota开展有关微生物组治疗药物的战略合作
日本大阪 (美国商业资讯) — 武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TOKYO:4502)今天宣布与NuBiyota LLC开展战略合作，共同开发微生物生态系统治疗产品，用于具有高度未获满足的医疗需求的胃肠病(GI)适应证。...
View ArticleClik here to view.
Hallstar的突破性抗衰老化学品Micah获得全球in-cosmetics®创新成分银奖
芝加哥 (美国商业资讯)–总部位于芝加哥的特种化学品公司Hallstar的突破性抗衰老新成分Micah获得2017年全球in-cosmetics®创新银奖。4月4日在伦敦召开的in-cosmetics®会议宣布了获奖者名单。该奖项旨在表彰新型活性或功能性成分的开发，该成分结合创新科学与产品特性，对制造商和终端用户有实质性效益。 Smart News...
View ArticleClik here to view.
Fujifilm Increases Production Capacity and Establishes New Process...
TOKYO FUJIFILM Corporation (President: Kenji Sukeno) will increase production capacity by investing about JPY14 billion ($130m) in the USA and UK in order to expand the business of its BioCDMO...
View ArticleClik here to view.
Shionogi presents New Data on Cefiderocol (S-649266), a Siderophore...
OSAKA, Japan Shionogi & Co., Ltd. today announced it will be presenting new data on cefiderocol (S-649266), an investigational siderophore cephalosporin in late stage development with activity...
View ArticleClik here to view.
Simulations Plus Establishes Distribution Channel in India with Electrolab
LANCASTER, Calif. Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals...
View ArticleClik here to view.
ReplicorがNAPによるHBV/HDVの1年間の機能的制御の達成とNAPの薬理作用機序に関する新知見を公表
モントリオール （ビジネスワイヤ） — 慢性HBV/HDV感染の治療薬に絞った開発に取り組む非公開バイオ製薬企業のReplicor Inc.は本日、2017年4月19～23日にオランダのアムステルダムで開催中の2017年欧州肝臓学会（EASL）年次総会で、HBV/HDV感染におけるNAP活性に関する有意義な新データを公表しました。 REP 301（HBV/HDV同時感染）およびREP...
View ArticleClik here to view.
Replicor披露 NAP功能性控制HBV和HDV的1年成果及有关NAP药理机制的新见解
蒙特利尔 (美国商业资讯) — 致力于根治慢性HBV和HDV感染的私营生物制药公司Replicor Inc.今天在欧洲肝脏研究学会(EASL) 2017年年会上披露了有关HBV和HDV感染中NAP活性的重大新数据，此次会议于2017年4月19-23日在荷兰阿姆斯特丹召开。 REP 301（HBV/HDV合并感染）和REP 401（HBV感染）研究的更新显示重大进展： 1. REP...
View ArticleClik here to view.
Synexus提升能力成为世界领先的研究单位网络
英国曼彻斯特 (美国商业资讯) 总部位于欧洲的Synexus和总部位于美国的Radiant Research今天宣布，两家公司的运营进行完全整合，成为一个拥有185家研究单位和1,500位员工的单一全球性研究单位网络。此举将创建世界上最大的临床试验单位网络，遍及11个国家，可获取关键临床开发市场中超过1亿患者，该网络在Synexus名下运营。...
View ArticleClik here to view.
Clik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Progesterone Capsules in the...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Progesterone Capsules, 100 mg and 200 mg, a...
View ArticleClik here to view.
Samsung Bioepis Obtains First Drug Approval in the United States, as the U.S....
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved RENFLEXIS™ (infliximab-abda), a biosimilar referencing Remicade®i (infliximab),...
View ArticleClik here to view.
Synaptive Medical Receives CE Mark in Europe and Regulatory Approval in...
TORONTO Synaptive Medical Inc., a medical device and technology company, has received its first CE Mark as well as regulatory approval in Australia. The approval opens European and Australian...
View ArticleClik here to view.
EOS imaging Announces Opening of First Two EOS® Systems in China
PARIS EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the first two installations of EOS systems in China at Nanjing Drum...
View ArticleClik here to view.
Clik here to view.
EpimAb Biotherapeutics Raises $25M in Series A Financing From International...
SHANGHAI EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today announced the completion of a $25 million Series A financing round....
View ArticleClik here to view.
AtriCure’s AtriClip System Surpasses 100,000 Units Sold Worldwide
MASON, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced it has sold more than...
View ArticleClik here to view.
Akebia and Otsuka Expand Relationship with Collaboration to Develop and...
CAMBRIDGE, Mass. & TOKYO Akebia Therapeutics, Inc. (NASDAQ:AKBA) and Otsuka Pharmaceutical Co., Ltd. today announced that they have expanded their collaboration for vadadustat by entering into a...
View Article